-

Ferrer Included in the Ranking of the World’s Most Ethical Companies® in 2026

BARCELONA, Spain--(BUSINESS WIRE)--Ferrer has been recognised by Ethisphere, a global leader in defining and advancing standards of ethical business practices, as one of the World’s Most Ethical Companies® 2026. Ferrer is the only Spanish pharmaceutical company to receive this recognition in 2026. This year, only 138 organisations worldwide, from 17 countries and 40 different industries, have achieved this distinction. One of the most prestigious international rankings, it recognizes organisations that have the highest standards of business integrity and responsible corporate practices.

By entering this ranking, the company, which holds ISO 37001 certification for anti-bribery and anti-corruption management systems and was recognised last year by Ethisphere with the U.S. Compliance Leader Verification™, further consolidates its commitment to corporate ethics. Ferrer continues embedding its ethical culture into its corporate decision-making and business activities.

“At Ferrer, ethics and responsibility are a critical part of our purpose to use business to fight for social justice. Being included among Ethisphere’s 138 most ethical companies in the world reinforces our conviction that generating real social change through our business activity is essential. Above all, this recognition reflects the daily commitment of everyone at Ferrer to build a company guided by integrity, respect and a genuine desire to contribute to a fairer and more sustainable society,” said Mario Rovirosa, CEO of Ferrer.

Meritxell Casas, Ferrer’s Chief Legal, IP & Compliance Officer, highlighted that “this recognition highlights an approach that defines Ferrer. Our ethics are reflected in how we go beyond regulatory compliance when making decisions and relating to others with rigour, coherence and integrity. We have a strong ethical framework across the company that guides our internal and external conduct and reinforces a way of doing business based on responsibility and transparency.”

Assessment process
To compile the World’s Most Ethical Companies® list, Ethisphere evaluates candidate companies using its Ethics Quotient® methodology, based on more than 240 documented proof points related to integrity practices. This analysis covers key pillars such as corporate governance, programme resources and structure, internal policies, and training and communication strategies. It also assesses risk management and audits, investigation processes and disciplinary measures, ethical culture, third-party risk management, and commitment to social and environmental impact.

These data are then analysed in depth by a broad panel of experts, who review and validate the information provided by each candidate company. This rigorous process establishes a benchmark that defines and aligns best practices in ethics and compliance across organisations worldwide and across all sectors.

About Ferrer
At Ferrer we use business to fight for social justice. We have long been a company that looks to do things differently; instead of maximizing shareholder returns, we reinvest around 50% of our profit in initiatives that give back to society. Back where it belongs. We go beyond compliance and are guided by the highest standards of sustainability, ethics and integrity. As such, we are the highest-rated B Corp pharma company in the world.

Founded in Barcelona in 1959, Ferrer offers transformative solutions for debilitating life-threatening diseases in more than one hundred countries. In line with our purpose, we have an increasing focus on pulmonary vascular and interstitial lung diseases and rare neurological diseases. Our 1,700-strong team is driven by the clear conviction the our business is not an end in itself, but a way to change lives.

We are Ferrer. Ferrer for good.

https://www.ferrer.com/es

Contacts

Sofia Prim
sprim@ferrer.com
+34 638 781 366

Ferrer

Details
Headquarters: Barcelona, Spain
CEO: Mario Rovirosa
Employees: 1.800
Organization: PRI

Release Versions

Contacts

Sofia Prim
sprim@ferrer.com
+34 638 781 366

Social Media Profiles
More News From Ferrer

Ferrer Receives FDA Fast Track Designation for FNP-223 in Progressive Supranuclear Palsy (PSP)

BARCELONA, Spain--(BUSINESS WIRE)--Ferrer, a B Corp-certified international pharmaceutical company, has announced that FNP-223, a novel therapy in-licensed from Asceneuron and aimed at slowing the development of progressive supranuclear palsy (PSP), has received Fast Track designation from the US Food & Drug Administration (FDA). FNP-223, a new molecular entity in active development for PSP, is in an ongoing Phase 2 study to evaluate its safety, efficacy, and pharmacokinetics in adult patie...

Ferrer is the Highest-performing Pharmaceutical Company in the World for Social and Environmental Impact According to B Corp

BARCELONA, Spain--(BUSINESS WIRE)--Spanish pharmaceutical company Ferrer has reaffirmed its status as a B Corp, an international certification awarded to companies that operate with a business model centered on positive impact and meet high social, environmental, and community standards. Ferrer has achieved a score of 136.4 points, making it the highest-rated pharmaceutical company in the world. Additionally, it now ranks as the third-highest scoring company across all sectors globally among th...

Ferrer is Recognized for Its Best-in-class Ethics and Compliance Program

BARCELONA, Spain--(BUSINESS WIRE)--Ferrer has achieved Compliance Leader Verification™, the prestigious recognition granted by Ethisphere, which distinguishes the pharmaceutical company as a global leader in upholding ethical and responsible corporate practices in its business operations. Ethisphere is a leading organization dedicated to advancing ethical business practices, and its recognition acknowledges organizations with an outstanding commitment to robust ethics and compliance programs. T...
Back to Newsroom